Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

What's Behind Allergan's Humdrum Q3 Results

TheMotleyFool

0 0

What's Behind Allergan's Humdrum Q3 ResultsPhoto, wide shot, wide-angle lens, Pharmaceutical company, Midday, harsh overhead sunlight, directional sunlightt, photo by Art Wolfe: https://img.midjourneyapi.xyz/temp/7ae4a134-dd01-4c80-a621-18399f5a2541.png

Some pharmaceutical stocks might be struggling somewhat in 2019, but not Allergan (NYSE: AGN). Its shares are up more than 30% so far this year, with a big boost coming from AbbVie's decision to acquire Allergan.

Allergan announced its third-quarter results before the market opened on Tuesday. While those results didn't weigh heavily on the stock, they didn't generate tremendous enthusiasm, either. Here are the highlights from Allergan's Q3 update.

Image source: Getty Images.

Source Fool.com

Like: 0

AGN

Teilen